Log in to save to my catalogue

Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from...

Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68449542

Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: Results of the oral enoximone in intravenous inotrope-dependent subjects trial

About this item

Full title

Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: Results of the oral enoximone in intravenous inotrope-dependent subjects trial

Publisher

New York, NY: Mosby, Inc

Journal title

The American heart journal, 2007-11, Vol.154 (5), p.861-869

Language

English

Formats

Publication information

Publisher

New York, NY: Mosby, Inc

More information

Scope and Contents

Contents

Background We determined whether low-dose oral enoximone could wean patients with ultra-advanced heart failure (UA-HF) from intravenous (IV) inotropic support. Chronic parenteral inotropic therapy in UA-HF is costly and requires an indwelling catheter. An effective and safe oral inotrope would have value. Methods In this placebo-controlled study, 2...

Alternative Titles

Full title

Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: Results of the oral enoximone in intravenous inotrope-dependent subjects trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68449542

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68449542

Other Identifiers

ISSN

0002-8703

E-ISSN

1097-6744

DOI

10.1016/j.ahj.2007.06.044

How to access this item